These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7546907)
1. Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism. Jacobsson B; Britton S; He Q; Karlsson A; Eriksson S AIDS Res Hum Retroviruses; 1995 Jul; 11(7):805-11. PubMed ID: 7546907 [TBL] [Abstract][Full Text] [Related]
2. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene. Wu S; Liu X; Solorzano MM; Kwock R; Avramis VI J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):1-9. PubMed ID: 8548339 [TBL] [Abstract][Full Text] [Related]
3. Activity of cellular thymidine kinase 1 in PBMC of HIV-1-infected patients: novel therapy marker. Gröschel B; Miller V; Doerr HW; Cinatl J Infection; 2000; 28(4):209-13. PubMed ID: 10961525 [TBL] [Abstract][Full Text] [Related]
4. Decrease in thymidylate kinase activity in peripheral blood mononuclear cells from HIV-infected individuals. Jacobsson B; Britton S; Törnevik Y; Eriksson S Biochem Pharmacol; 1998 Aug; 56(3):389-95. PubMed ID: 9744577 [TBL] [Abstract][Full Text] [Related]
5. Ethanol decreases the efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line. Prakash O; Tang ZY; Zhou P; Peng X; Kolls J; Shellito JE; Nelson S Alcohol Clin Exp Res; 2002 Mar; 26(3):295-302. PubMed ID: 11923581 [TBL] [Abstract][Full Text] [Related]
6. Alteration of thymidine kinase activity in cells treated with an antiviral agent. Turriziani O; Antonelli G; Verri A; Tozzi V; Ferri F; Riva E; Bambacioni F; Dianzani F J Biol Regul Homeost Agents; 1995; 9(2):47-51. PubMed ID: 9127632 [TBL] [Abstract][Full Text] [Related]
8. Zidovudine and lamivudine: results of phase III studies. Staszewski S J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510 [TBL] [Abstract][Full Text] [Related]
9. Thymidine and 3'-azido-3'-deoxythymidine metabolism in human peripheral blood lymphocytes and monocyte-derived macrophages. A study of both anabolic and catabolic pathways. Arnér ES; Valentin A; Eriksson S J Biol Chem; 1992 Jun; 267(16):10968-75. PubMed ID: 1597439 [TBL] [Abstract][Full Text] [Related]
10. Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase. Antonelli G; Turriziani O; Verri A; Narciso P; Ferri F; D'Offizi G; Dianzani F AIDS Res Hum Retroviruses; 1996 Feb; 12(3):223-8. PubMed ID: 8835200 [TBL] [Abstract][Full Text] [Related]
11. Quantitation of human immunodeficiency virus (HIV) with respect to disease stage and zidovudine (AZT) therapy. Ved Brat SS; Shepherd LP; Boulberhane A; Pierce PF; Hellman KB AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1271-81. PubMed ID: 1520539 [TBL] [Abstract][Full Text] [Related]
12. Use of herpes simplex virus thymidine kinase to improve the antiviral activity of zidovudine. Guettari N; Loubière L; Brisson E; Klatzmann D Virology; 1997 Sep; 235(2):398-405. PubMed ID: 9281520 [TBL] [Abstract][Full Text] [Related]
13. Low-dose, sublingual AZT-monophosphate therapy for HIV+ patients? Johnson S Med Hypotheses; 2001 Mar; 56(3):409-10. PubMed ID: 11359372 [TBL] [Abstract][Full Text] [Related]
14. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection. Avramis VI; Kwock R; Solorzano MM; Gomperts E J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464 [TBL] [Abstract][Full Text] [Related]
15. Determinants of individual variation in intracellular accumulation of anti-HIV nucleoside analog metabolites. Paintsil E; Dutschman GE; Hu R; Grill SP; Wang CJ; Lam W; Li FY; Ghebremichael M; Northrup V; Cheng YC Antimicrob Agents Chemother; 2011 Feb; 55(2):895-903. PubMed ID: 21078952 [TBL] [Abstract][Full Text] [Related]
16. Zidovudine phosphorylation after short-term and long-term therapy with zidovudine in patients infected with the human immunodeficiency virus. Peter K; Gambertoglio JG Clin Pharmacol Ther; 1996 Aug; 60(2):168-76. PubMed ID: 8823234 [TBL] [Abstract][Full Text] [Related]
17. Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patients. Turriziani O; Gianotti N; Bambacioni F; Manconi PE; Lazzarin A; Antonelli G AIDS Res Hum Retroviruses; 2004 Jul; 20(7):701-3. PubMed ID: 15307913 [TBL] [Abstract][Full Text] [Related]
18. Thymidine and zidovudine metabolism in chronically zidovudine-exposed cells in vitro. Agarwal RP; Mian AM Biochem Pharmacol; 1991 Jul; 42(4):905-11. PubMed ID: 1867645 [TBL] [Abstract][Full Text] [Related]
19. [Genetically controlled pharmacomodulation: application to the treatment of HIV infection]. Caruso M; Klatzmann D C R Acad Sci III; 1994 Nov; 317(11):1027-30. PubMed ID: 7882139 [TBL] [Abstract][Full Text] [Related]
20. Intracellular metabolism of 3'-azidothymidine in isolated human peripheral blood mononuclear cells. Törnevik Y; Jacobsson B; Britton S; Eriksson S AIDS Res Hum Retroviruses; 1991 Sep; 7(9):751-9. PubMed ID: 1742082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]